Octreotide: all 128 studies that test it
Page 1 of 2. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With AcromegalyNot yet recruitingNCT07623824Phase 3
- Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)Not yet recruitingNCT06974344Phase 4
- Human Models of Selective Insulin Resistance: Pancreatic ClampNot yet recruitingNCT06558422Phase 1
- Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.RecruitingNCT06085976Phase 2
- Role of Octreotide in Non Variceal BleedingRecruitingNCT06062719Phase 2/3
- A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLDActive, not recruitingNCT05281328Phase 2/3Results posted
- A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With AcromegalyCompletedNCT04076462Phase 3Results posted
- Palliative Management of Inoperable Malignant Bowel ObstructionTerminatedNCT04027348Phase 2Results posted
- Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal VaricesTerminatedNCT03624517Phase 4Results posted
- Effect of Hyperglycemia on Microvascular Perfusion in Healthy AdultsCompletedNCT03520569Early Phase 1Results posted
- A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus LanreotideCompletedNCT03289741Phase 4Results posted
- Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in AcromegalyStatus unknownNCT03252353Phase 3Results posted
- Trial Using Octreotide to Enhance Liver Recovery After HepatectomyTerminatedNCT03179995Phase 2Results posted
- Octreotide for Management of Bronchorrhea in Mechanically Ventilated PatientsCompletedNCT02916433Phase 2Results posted
- Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in AcromegalyCompletedNCT02685709Phase 3Results posted
- Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)CompletedNCT02299089Phase 2Results posted
- Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast CancerTerminatedNCT02294786Phase 2Results posted
- Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.CompletedNCT02235987Phase 2Results posted
- Effect of Octreotide on the Colonic Motility in Pediatric PatientsCompletedNCT01917773Phase 4Results posted
- P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid SyndromeTerminatedNCT01886287Phase 2Results posted
- Effects of Sandostatin LAR® in AcromegalyCompletedNCT01424241Phase 4Results posted
- Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for AcromegalyCompletedNCT01412424Phase 3Results posted
- Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal BleedingCompletedNCT00966355Phase 4Results posted
- A Study of Cixutumumab (IMC-A12) in Islet Cell CancerCompletedNCT00781911Phase 2Results posted
- Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid DiseaseCompletedNCT00690430Phase 3Results posted
- Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced DiarrheaCompletedNCT00582426Phase 3Results posted
- Ultrasound Guided Octreotide LAR Injection in AcromegalyCompletedNCT00552071Phase 4Results posted
- Sandostatin for Patients With Androgen Independent Prostate CancerTerminatedNCT00510224Phase 2Results posted
- AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsCompletedNCT00427349Phase 2Results posted
- Octreotide in Severe Polycystic Liver DiseaseCompletedNCT00426153Phase 2/3Results posted
- Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)TerminatedNCT00399893Not applicableResults posted
- Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled AcromegalyCompletedNCT00372697Phase 3Results posted
- Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal CarcinomatosisCompletedNCT00332696Phase 2Results posted
- Octreotide in Treating Patients With Cancer-Related Malignant AscitesCompletedNCT00182754Phase 3Results posted
- Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the MidgutCompletedNCT00171873Phase 3Results posted
- RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine CarcinomaCompletedNCT00113360Phase 2Results posted
- Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in CirrhosisCompletedNCT00108355Phase 4Results posted
- Treatment With Octreotide in Patients With LymphangioleiomyomatosisCompletedNCT00005906Phase 2Results posted
- Intranasal Delivery of Octreotide for Treatment of Diabetic Macular EdemaWithdrawnNCT06881888Phase 1
- Real-world Study on Adjuvant Octreotide Therapy in pNETsCompletedNCT06080204Not applicable
- A Single-dose Study of Octreotide Injection in Healthy Adult SubjectsCompletedNCT05761431Phase 1
- Pancreatic Clamp in NAFLDCompletedNCT05724134Phase 1
- Octreotide Improves Human Lymphatic Fluid Transport a Translational TrialCompletedNCT05683444Early Phase 1
- The Effect of Octreotide on Wound Drainage After MastectomyCompletedNCT05682209Phase 4
- A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)TerminatedNCT05364944Phase 1
- Effect of Octreotide on SalivaCompletedNCT05340192Phase 1
- Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled StudyStatus unknownNCT05199038Phase 4
- A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NETActive, not recruitingNCT05050942Phase 3
- A Feasibility Study of Octreotide Infusion During Liver Transplant.Active, not recruitingNCT04941911Phase 2
- Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric CancerCompletedNCT04871204Phase 2
- Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal SyndromeCompletedNCT04522297Not applicable
- Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.Status unknownNCT04353193Phase 4
- Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation OptimisationTerminatedNCT04140409Phase 4
- Octreotide LAR in the Induction of Immunologic Response in NENs PatientsCompletedNCT04129255Phase 2
- A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With AcromegalyCompletedNCT04125836Phase 3
- Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic ShockWithdrawnNCT03891849Not applicable
- Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine TumorsCompletedNCT03879694Phase 1
- Tolvaptan-Octreotide LAR Combination in ADPKDCompletedNCT03541447Phase 2
- Impact of Prophylactic Octreotide to Pancreatic Exocrine SecretionStatus unknownNCT02920567Not applicable
- Octreotide in Patients With GI Bleeding Due to Rendu-Osler-WeberStatus unknownNCT02874326Phase 2
- Octreotide in the Prevention of Postoperative Complications After PancreaticoduodenectomyCompletedNCT02474914Not applicable
- Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage SurgeryStatus unknownNCT02437825Phase 2
- Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin AnaloguesStatus unknownNCT02427295Phase 4
- Octreotide LAR as Maintenance Treatment for Patients With NECStatus unknownNCT02409849Phase 2
- Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for CancerCompletedNCT02385617Not applicable
- Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to AngiodysplasiasCompletedNCT02384122Phase 3
- The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal SurgeryCompletedNCT02381249Not applicable
- Combination of Everolimus and Octreotide LAR in Aggressive Recurrent MeningiomasCompletedNCT02333565Phase 2
- Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173CompletedNCT02217839Phase 1
- Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy SubjectsCompletedNCT02195635Phase 1
- Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy BleedingTerminatedNCT02032784Phase 4
- Investigation of the Effects of Obesity Surgery on Appetitive BehaviourCompletedNCT02010385Not applicable
- Etiology, Assessment and Treatment of Post-gastric Bypass Severe HypoglycemiaCompletedNCT01865760Not applicable
- Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical TargetCompletedNCT01618513Phase 4
- Ghrelin Suppression by Octreotide in Prader-WilliStatus unknownNCT01613495Not applicable
- Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal FailureWithdrawnNCT01587222Phase 2
- Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NETCompletedNCT01567488Phase 2
- Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelTerminatedNCT01469338Phase 2
- Long-term Safety and Efficacy Study of Octreotide Implant in Patients With AcromegalyTerminatedNCT01295060Phase 3
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaCompletedNCT01204476Phase 1
- Open Label Study of Octreotide Implant in Patients With AcromegalyCompletedNCT00913055Phase 2
- Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid SyndromeTerminatedNCT00884715Phase 1/2
- Octreotide for the Treatment of Sulfonylurea-Associated HypoglycemiaCompletedNCT00804297Phase 3
- Efficacy and Safety Study of Octreotide Implant in Patients With AcromegalyTerminatedNCT00765323Phase 3
- Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal SyndromeTerminatedNCT00742339Phase 2/3
- Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic PatientsTerminatedNCT00642421Phase 3
- Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using OctreotideCompletedNCT00584298Phase 1
- The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal BleedCompletedNCT00534677Phase 4
- Preoperative Octreotide Treatment of AcromegalyCompletedNCT00521300Phase 4
- Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine TumorsTerminatedNCT00466856Phase 2
- Treatment of Idiopathic Pulmonary Fibrosis with Long Acting OctreotideCompletedNCT00463983Phase 1/2
- Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy VolunteersCompletedNCT00432068Phase 1
- Efficacy of Octreotide Acetate and Cabergoline in Patients With AcromegalyCompletedNCT00376064Phase 4
- Efficacy of Octreotide Treatment in Patients With Primary Inoperable ThymomaCompletedNCT00332969Phase 2
- Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine HeadacheStatus unknownNCT00274170Phase 1/2
- Treatment of Orthostatic IntoleranceActive, not recruitingNCT00262470Phase 1/2
- Octreotide in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT00257426Phase 2
- Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00250796Phase 2
- Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or MacroadenomasTerminatedNCT00242541Phase 4
- Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular CarcinomaCompletedNCT00241020Phase 3